Skip to main content
. Author manuscript; available in PMC: 2022 Jun 9.
Published in final edited form as: JAMA. 2021 Jan 5;325(1):69–80. doi: 10.1001/jama.2020.18936

Table.

Vaccinations in Patients With Inflammatory Bowel Disease (IBD)a

Vaccination Live or inactivated Patient population Comment(s)
HepatitisA Inactivated All patients with IBD
Hepatitis B Inactivated All patients with IBD
Influenza Inactivated All patients with IBD An exception is the live attenuated intranasal vaccine, which is contraindicated in immunocompromised patients
Pneumonia Inactivated All patients with IBD Vaccination includes pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine; timing of administration per national guidelines
Tetanus, diphtheria, pertussis Inactivated All patients with IBD
Special considerations
Meningitis Inactivated Adolescents (per national guidelines)
Human papillomavirus Inactivated Adolescents and young adults (per national guidelines)
Herpes zoster Inactivated Adults older than 50 y (per national guidelines) An exception is the live vaccine, which is contraindicated in immunocompromised patients
Live vaccines (contraindicated in immunocompromised patients)
Influenza (intranasal) Live Use injectable inactivated influenza vaccine
Shingles Live Use the recombinant inactivated vaccine
Measles, mumps, rubella Live
Rotavirus Live Delay until 6 mo of age if mother is receiving biologic therapy for Crohn disease
Varicella Live
Yellow fever Live
Smallpox Live
Oral typhoid Live Use injectable inactivated typhoid vaccine
Bacille Calmette-Guérin Live
Adenovirus Live
Oral cholera Live
a

Adapted from Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241–258. doi:10.1038/ajg.2016.537.